The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atorvastatin Bluefish 30 mg Film-coated tablets



Bluefish Pharmaceuticals ABPA1436/027/003

Main Information

Trade NameAtorvastatin Bluefish 30 mg Film-coated tablets
Active SubstancesAtorvastatin calcium trihydrate
Dosage FormFilm-coated tablet
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/027/003

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA05 atorvastatin

Status

License statusAuthorised
Licence Issued30/11/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back